JS

Jagtar Singh

Active Director Director DIN 09226198
DIN 09226198 First appointment Jul 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value •••• Premium profile

About Jagtar Singh

Data last updated:

Jagtar Singh is a Director at Precious Pharma Private Limited (since 2021). The company operates in Healthcare. Precious Pharma Private Limited reported revenue of ₹5.9 Lakh (FY 2023).

DIN 09226198
Primary Designation Director
Industry Healthcare
First Appointment 05 Jul 2021
Oldest Company Age 5 yrs
Largest company Precious Pharma Private Limited · ₹5.9 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Precious Pharma Private Limited U52609PB2021PTC053748
Director05 Jul 20212021₹5.9 Lakh (FY 2023)Active

Board colleagues of Jagtar Singh

NameDINCompanyDesignation
Rajinder Singh09226197Precious Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Precious Pharma Private Limited
Premium access

Shareholding and investment profile for Jagtar Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jagtar Singh

Jagtar Singh currently holds 1 directorship: Precious Pharma Private Limited (Director, since 05 Jul 2021, revenue ₹5.9 Lakh (FY 2023)).

Jagtar Singh was first appointed on 05 Jul 2021 as Director at Precious Pharma Private Limited.

The current boards of Jagtar Singh's companies include Rajinder Singh (Precious Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available